Psyence Biomedical (Psyence Biomedical) Operating Cash Flow per Share : $ (TTM As of Mar. 2023)

View and export this data going back to 2024. Start your Free Trial

What is Psyence Biomedical Operating Cash Flow per Share?

Psyence Biomedical's operating cash flow per share for the six months ended in Mar. 2023 was $-0.11. Psyence Biomedical does not have enough years/quarters to calculate the operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Psyence Biomedical's Operating Cash Flow per Share or its related term are showing as below:

PBM's 3-Year OCF Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 3.55
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Psyence Biomedical Operating Cash Flow per Share Historical Data

The historical data trend for Psyence Biomedical's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Biomedical Operating Cash Flow per Share Chart

Psyence Biomedical Annual Data

Trend

Mar21

Mar22

Mar23

Operating Cash Flow per Share

-0.11

Psyence Biomedical Semi-Annual Data
	Mar21	Mar22	Mar23
Operating Cash Flow per Share	-	-0.11	-0.11

Competitive Comparison of Psyence Biomedical's Operating Cash Flow per Share

For the Biotechnology subindustry, Psyence Biomedical's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Psyence Biomedical's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Psyence Biomedical's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Psyence Biomedical's Price-to-Operating-Cash-Flow falls into.

Psyence Biomedical Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Psyence Biomedical's Operating Cash Flow per Share for the fiscal year that ended in Mar. 2023 is calculated as

Operating Cash Flow per Share (A: Mar. 2023 )	=	Cash Flow from Operations (A: Mar. 2023 )	/	Shares Outstanding (Diluted Average) (A: Mar. 2023 )
	=	-1.416	/	12.745
	=	-0.11

Psyence Biomedical's Operating Cash Flow per Share for the quarter that ended in Mar. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2023 )	=	Cash Flow from Operations (Q: Mar. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2023 )
	=	-1.416	/	12.745
	=	-0.11

Psyence Biomedical Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Psyence Biomedical's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Psyence Biomedical (Psyence Biomedical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Psyence Biomedical Ltd (NAS:PBM) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

121 Richmond Street West, Penthouse Suite 1300, Toronto, ON, CAN, M5H 2K1

Website

https://www.psyence.com

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Psyence Biomedical (Psyence Biomedical) Headlines

From GuruFocus

Thinking about buying stock in Psyence Biomedical, Micron Technology, Conservative Broadcast Media Journalism, Qualcomm, or Cibus?

By PRNewswire • 02-12-2024